Publications by Wim Van Criekinge.

2017

Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy
K. van Kessel, W. Beukers, I. Lurkin, A. Ziel-van der Made, K. van der Keur, J. Boormans, L. Dyrskjøt, M. Márquez, T. Ørntoft, F. Real, U. Segersten, N. Malats, P. Malmström, W. Van Criekinge and E. Zwarthoff
(2017) JOURNAL OF UROLOGY, 197,

2016

RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis
M. Clausen, L. Melchers, M. Mastik, L. Slagter-Menkema, H. Groen, B. van der Laan, W. Van Criekinge, T. De Meyer, S. Denil, B. van der Vegt, G. Wisman, J. Roodenburg and E. Schuuring
(2016) EPIGENETICS, 11,

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients
T. Seremet, A. Koch, Y. Jansen, M. Schreuer, S. Wilgenhof, V. Del Marmol, D. Liènard, K. Thielemans, K. Schats, M. Kockx, W. Van Criekinge, P. Coulie, T. De Meyer, N. van Baren and B. Neyns
(2016) JOURNAL OF TRANSLATIONAL MEDICINE, 14, 232

Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies
L. Van Neste, A. Partin, G. Stewart, J. Epstein, D. Harrison and W. Van Criekinge
(2016) PROSTATE, 76,

Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score
L. Van Neste, R. Hendriks, S. Dijkstra, G. Trooskens, E. Cornel, S. Jannink, H. de Jong, D. Hessels, F. Smit, W. Melchers, G. Leyten, T. de Reijke, H. Vergunst, P. Kil, B. Knipscheer, C. Hulsbergen-van de Kaa, P. Mulders, I. van Oort, W. Van Criekinge and J. Schalken
(2016) EUROPEAN UROLOGY, 70,

Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma
M. Clausen, L. Melchers, M. Mastik, L. Slagter-Menkema, H. Groen, B. van der Laan, W. Van Criekinge, T. De Meyer, S. Denil, G. Wisman, J. Roodenburg and E. Schuuring
(2016) GENES CHROMOSOMES & CANCER, 55,

Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma
R. Wang, R. van Leeuwen, A. Boers, H. Klip, T. De Meyer, R. Steenbergen, W. Van Criekinge, A. van der Zee, E. Schuuring and G. Wisman
(2016) ONCOTARGET, 7,

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3
A. Boers, R. Wang, R. van Leeuwen, H. Klip, G. de Bock, H. Hollema, W. Van Criekinge, T. De Meyer, S. Denil, A. van der Zee, E. Schuuring and G. Wisman
(2016) CLINICAL EPIGENETICS, 8, 29

Evaluation of an epigenetic profile for the detection of bladder cancer in patients with hematuria
K. van Kessel, L. Van Neste, I. Lurkin, E. Zwarthoff and W. Van Criekinge
(2016) JOURNAL OF UROLOGY, 195,

DNA methylation profiling of primary neuroblastoma tumors using methyl-CpG-binding domain sequencing
A. Decock, M. Ongenaert, W. Van Criekinge, F. Speleman and J. Vandesompele
(2016) SCIENTIFIC DATA, 3, 160004